BCCOY (BICO Group AB) SpecialCharges

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BCCOY BICO Group AB BCCOY
51 GF Score
Price $0.59
GF Value $0.95
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is BICO Group AB SpecialCharges?

Special Charges only applies to banks.

BCCOY
51GF Score
BICO Group AB BCCOY
SpecialCharges is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is BICO Group AB (BCCOY) Overvalued in 2026?

Based on GuruFocus' analysis, BICO Group AB stock appears to be undervalued. The current stock price of $0.59 is trading 38.2% below its estimated GF Value™ of $0.95. GuruFocus considers BICO Group AB to be Possible Value Trap.

Key valuation signals for BCCOY:

  • SpecialCharges:
  • GF Value™: $0.95 vs. price of $0.59 (38.2% below fair value)
  • GF Score™: 51/100 with 6 warning signs

No single metric tells the full story. See the BCCOY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BICO Group AB Business Description

Address Grafiska vagen 2B, Gothenburg, SWE, 412 63
BICO Group AB is a Swedish life science technology company that develops and sells laboratory automation, bioprinting, and cell biology equipment and software. Its products include automated liquid handling and single-cell dispensing systems, 3D bioprinters and cell culture platforms, live-cell imaging and microscopy instruments, and laboratory workflow automation software. The company serves pharmaceutical, biotechnology, diagnostics, and academic research customers, primarily in Europe and North America. BICO operates through two segments: Life Science Solutions, which includes brands such as CELLINK, CYTENA, DISPENDIX, SCIENION, Cellenion, and QInstruments, and Lab Automation, centered on Biosero and its Green Button Go software and integration services. Revenue comes mainly from instrument and consumable sales, software licenses, and automation integration and service contracts, with Life Science Solutions generating the larger share.
51GF Score

Get the complete analysis for BCCOY

SpecialCharges is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.59
Price
$0.95
GF Value